---
title: "Pemoline - Attention Deficit Hyperactivity Disorder"
sidebar: mydoc_sidebar
permalink: db01230-mesh-d001289-1.html
toc: false 
---


Path ID: `DB01230_MESH_D001289_1`
{% include image.html url="images/db01230-mesh-d001289-1.png" file="db01230-mesh-d001289-1.png" alt="db01230-mesh-d001289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D010389 | Pemoline | Drug |
| GO:0061527 | Dopamine secretion, neurotransmission | BiologicalProcess |
| MESH:D001289 | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pemoline | POSITIVELY REGULATES | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | TREATS | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Comment: Pemoline is generally considered dopaminergic, but its precise method of action hasn't yet been definitively determined.

Reference: 
  - [https://en.wikipedia.org/wiki/Pemoline](https://en.wikipedia.org/wiki/Pemoline) Pemoline
  - [https://go.drugbank.com/drugs/DB01230](https://go.drugbank.com/drugs/DB01230)
